Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06118502 · ClinicalTrials.gov registry record · NA
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
A NA study of Cigarette Smoking and Smoking Behaviors, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 544
- Enrollment target
- 1
- Study location
NCT06118502 is a NA study of Cigarette Smoking and Smoking Behaviors that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 544 participants, above the 164-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (232% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06118502, a NA study of Cigarette Smoking and Smoking Behaviors, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 544 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to find out if treatment decision making can be improved for smokers who find it difficult to quit with medications. Everyone who participates in this study will receive free product, either nicotine replacement therapies (patches and lozenges), varenicline, or a harm reduction product (e-cigarette) for a full 12 weeks. Most participants will receive some combination of these treatments, depending on individual response to each. All visits and study assessments will be entirely remote. All treatments will be provided free of charge for the first 12 weeks. After that, the study team will contact the participants 6 months after the first study phone call to complete another survey. The study lasts six months and will involve 8 surveys.
Conditions Studied
Interventions
- BEHAVIORAL Switching to a different medication
- BEHAVIORAL Continued use of the same medication
- BEHAVIORAL Switching to a harm reduction tobacco product
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 544 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06118502
The ClinicalTrials.gov registry entry for NCT06118502 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 544 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 164-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (232% higher). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cigarette Smoking appearing as the primary indexed condition, and to 3 interventions - of which Switching to a different medication is the first listed.
NCT06118502 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT06118502 about?
NCT06118502 is a clinical study titled "A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse". This is a research study to find out if treatment decision making can be improved for smokers who find it difficult to quit with medications. Everyone who participates in this study will receive free product, either nicotine replacement therapies (patches and lozenges), varenicline, or a harm reduct...
What is the current status of trial NCT06118502?
This trial is currently recruiting. It is a NA study. The enrollment target is 544 participants. The study started on 2024-03-25. Estimated completion is 2028-03-31.
What conditions does trial NCT06118502 study?
This clinical trial studies the following conditions: Cigarette Smoking, Smoking Behaviors, Treatment.
What interventions are being tested in trial NCT06118502?
The interventions under investigation include: Switching to a different medication (BEHAVIORAL), Continued use of the same medication (BEHAVIORAL), Switching to a harm reduction tobacco product (BEHAVIORAL).
Who is sponsoring clinical trial NCT06118502?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06118502 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
RECRUITING · NA
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.